--- title: Buy Edarbi (Azilsartan medoxomil) 40mg Pills Online description: Edarbi (Azilsartan medoxomil) 40mg pills lower high blood pressure in adults. Order from our secure online pharmacy for verified quality and reliable delivery. type: product language: en url: https://liabilis.com/order-edarbi-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 59.99 price_max: 269.99 currency: USD offers: - name: 40mg x 30 pills price: 59.99 - name: 40mg x 60 pills price: 107.99 - name: 40mg x 90 pills price: 152.99 - name: 40mg x 120 pills price: 191.99 - name: 40mg x 180 pills price: 269.99 --- # Buy Edarbi (Azilsartan medoxomil) 40mg Pills Online Edarbi, containing azilsartan medoxomil, is an angiotensin receptor blocker developed by Takeda. It treats hypertension to reduce risks of stroke and heart attack. For adults with elevated blood pressure. Our online pharmacy offers a reliable way to access Edarbi in 40mg pills. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **40mg** | 30 pills | **$59.99** | $2.00 | In Stock | | **40mg** | 60 pills | **$107.99** | $1.80 | In Stock | | **40mg** | 90 pills | **$152.99** | $1.70 | In Stock | | **40mg** | 120 pills | **$191.99** | $1.60 | In Stock | | **40mg** | 180 pills | **$269.99** | $1.50 | In Stock | [Buy Now](https://liabilis.com/order-edarbi-online-en.html) ## Introduction Edarbi is a tablet formulation that delivers the active compound azilsartan medoxomil, an angiotensin II receptor blocker (ARB) used to lower blood pressure. It is supplied as a 40 mg pill and belongs to the class of antihypertensive agents. While its primary indication is the treatment of hypertension, clinicians sometimes consider it for related cardiovascular conditions under specialist supervision. ## Quick Reference Facts **Active Ingredient** : azilsartan medoxomil **Form** : pill 40 mg **Primary and Off-Label Uses** : • Hypertension (approved) : • Heart failure (off-label) : • Diabetic kidney disease (off-label) ## What is Edarbi? Edarbi is the generic version of medications containing the active compound azilsartan medoxomil. It is classified as an angiotensin II receptor blocker, a subgroup of antihypertensive drugs that block the effects of angiotensin II on vascular smooth muscle. The medication is manufactured by multiple licensed producers worldwide; specific company names vary by region but all adhere to international quality standards. Marketed under brand names such as Edarbi and others, the generic formulation offers the same therapeutic effect at a lower cost, providing a bio-equivalent alternative to branded products. ## How Edarbi Works Azilsartan medoxomil is a pro-drug that is rapidly converted in the gut to azilsartan, the active moiety. Azilsartan binds selectively to the angiotensin II type 1 (AT1) receptor, preventing angiotensin II from causing vasoconstriction, aldosterone release, and sympathetic activation. The blockade leads to dilation of arterioles, reduced peripheral resistance, and a modest increase in sodium excretion, collectively lowering systolic and diastolic blood pressure. Onset of action typically occurs within 2 hours after oral intake, and the antihypertensive effect persists for 24 hours, allowing once-daily dosing. The drug is primarily eliminated unchanged via the bile and feces, with a minor renal component; hepatic metabolism is not a major pathway, reducing the potential for drug-drug interactions mediated by cytochrome P450 enzymes. ## Conditions Treated with Edarbi - **Essential hypertension** - By blocking AT1 receptors, Edarbi reduces vascular tone and circulating volume, achieving target blood-pressure goals in most adults. - **Resistant hypertension** - When combined with other antihypertensives, the ARB mechanism complements different therapeutic pathways, helping patients reach control when monotherapy fails. - **High-risk cardiovascular profiles** - Although not an approved indication, clinicians sometimes incorporate Edarbi into regimens for patients with left-ventricular hypertrophy due to its ability to attenuate remodeling mediated by angiotensin II. ## Is Edarbi the Right Medication for You? Edarbi is most appropriate for adults with confirmed primary hypertension who have not responded adequately to lifestyle modification alone. It is particularly advantageous for patients who experience cough with ACE inhibitors, as ARBs do not affect bradykinin metabolism. Contraindications include pregnancy, breastfeeding, and known hypersensitivity to azilsartan or any tablet excipients. Caution is advised in individuals with severe renal impairment, hyperkalemia, or concurrent use of potassium-sparing diuretics. Patients with a history of angioedema should avoid ARBs unless evaluated by a specialist. ## Buying Edarbi from [our online pharmacy](https://liabilis.com/order-edarbi-online-en.html) ### Why Choose Our Service? Our platform offers a reliable way to obtain Edarbi when local pharmacies face stock shortages or when cost barriers limit access. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. ### Pricing & Access Because Edarbi is available as a generic, you benefit from pricing that approaches the manufacturer's wholesale cost, providing a significant saving compared with brand-name equivalents. ### Discreet Delivery Orders are shipped in neutral, tamper-proof packaging, with express delivery typically within 7 days or standard airmail in approximately 3 weeks, protecting your privacy throughout the process. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** - One 40 mg tablet taken orally once daily, with or without food. - **Missed dose** - If a dose is forgotten, take it as soon as remembered unless it is within 12 hours of the next scheduled dose; in that case, skip the missed tablet and resume the regular schedule. - **Overdose** - Symptoms may include profound hypotension, dizziness, or fainting. Seek immediate medical attention; supportive care and monitoring of blood pressure are the primary interventions. - **Administration notes** - Avoid concurrent consumption of large amounts of alcohol, as it may potentiate hypotensive effects. Do not operate heavy machinery until you know how Edarbi affects you. ## Safety Information ### ⚠️ Who Should Not Take Edarbi - Pregnant or breastfeeding women - Patients with known hypersensitivity to azilsartan medoxomil or tablet excipients - Individuals with severe hepatic impairment (manufacturer advises caution) ### Common Side Effects - Dizziness or light-headedness (especially after the first dose) - Headache - Mild gastrointestinal discomfort (nausea, abdominal pain) These effects are usually transient and resolve without intervention. ### Serious Side Effects (Seek Immediate Medical Help) - Angioedema (swelling of face, lips, tongue, or throat) - Severe hypotension causing fainting - Acute renal failure reflected by a rapid rise in serum creatinine If any of these occur, discontinue Edarbi and obtain emergency care. ### Drug & Food Interactions - **Potassium-sparing diuretics (e.g., spironolactone)** - May increase serum potassium, risking hyperkalemia. - **Non-steroidal anti-inflammatory drugs (NSAIDs)** - Can attenuate antihypertensive effect and worsen renal function. - **Concurrent ACE inhibitors** - Combined use heightens the risk of hypotension, renal impairment, and hyperkalemia; avoid unless directed by a specialist. ## Off-Label and Investigational Uses of Edarbi Clinical studies suggest that azilsartan medoxomil may provide renal protection in patients with diabetic nephropathy, reducing albuminuria beyond blood-pressure control. Some cardiology practices employ it off-label for chronic heart failure management, leveraging its ability to blunt maladaptive remodeling. These applications have not received formal regulatory approval, and their safety and efficacy remain under investigation. Use of Edarbi for such purposes should only occur under the direct supervision of a qualified healthcare provider. ## Storage & Handling - Store tablets at 20-25 °C (68-77 °F) in a dry place, protected from moisture and direct sunlight. - Keep the container tightly closed and out of reach of children. - Do not use tablets after the expiration date printed on the package. - Dispose of unused medication through a pharmacy take-back program or according to local hazardous-waste regulations. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Edarbi tablets?** Yes, but keep them in the original labeled container and carry a copy of the prescription or a physician’s note to satisfy customs regulations. - **Does caffeine affect the blood-pressure-lowering action of Edarbi?** Moderate caffeine intake does not significantly alter Edarbi’s efficacy, though excessive consumption may counteract antihypertensive effects. - **Should I avoid taking Edarbi at night?** Edarbi can be taken at any time of day; consistency is more important than the specific hour. If nocturnal hypotension occurs, discuss timing adjustments with your clinician. **Product & Formulation Details** - **What do Edarbi tablets look like?** Generic tablets are typically round, white, and imprinted with “40 mg”. Appearance may vary slightly among manufacturers. - **Are any of the tablet’s inactive ingredients of concern?** Common excipients include lactose, microcrystalline cellulose, and magnesium stearate. Patients with severe lactose intolerance should consult their pharmacist. **Regulatory & Safety Nuances** - **Will Edarbi appear on a standard drug test for athletes?** ARBs are not prohibited substances under most sports anti-doping regulations, but athletes should verify current lists before competition. - **Is Edarbi safe for elderly patients?** Older adults may be more prone to orthostatic hypotension; a lower starting dose or careful monitoring is advisable. - **Can Edarbi be used in patients with mild liver disease?** Mild hepatic impairment does not require dose adjustment, but severe liver dysfunction warrants caution and possible avoidance. **Scientific & Clinical Curiosity** - **What distinguishes azilsartan from other ARBs?** Azilsartan has a higher binding affinity for the AT1 receptor, potentially offering more potent blood-pressure reduction at lower doses. - **When was azilsartan medoxomil first approved?** The compound received regulatory approval in the early 2010s for hypertension treatment after demonstrating non-inferiority to existing ARBs in phase III trials. ## Glossary **Angiotensin II Receptor Blocker (ARB)** : A class of drugs that inhibit the action of angiotensin II at the AT1 receptor, leading to vasodilation and reduced blood pressure. **Pro-drug** : An inactive substance that is metabolized in the body to produce the active pharmacological agent. **Hyperkalaemia** : An elevated level of potassium in the blood, which can cause cardiac rhythm disturbances. **Bioequivalence** : Demonstration that two pharmaceutical products release the same amount of active ingredient into the bloodstream at the same rate. ## Disclaimer The information provided about **Edarbi** is intended for general educational purposes and does not replace personalized medical counsel. Treatment decisions, including any off-label applications, should be undertaken only under the guidance of a qualified healthcare professional. Readers are presumed to be responsible adults capable of making informed health choices. Our pharmacy service offers access to **Edarbi** for individuals who encounter limited availability through conventional pharmacies or who seek cost-effective generic alternatives. Always discuss any medication changes with your physician before initiating, modifying, or discontinuing therapy.